Purchase Order 75N92B25P00257
Award Date
8/21/25
Potential Completion Date
8/20/26
Potential Value
$25K
Awardee
10X Genomics, Inc.
Ultimate Awardee
Not listed
NAICS Category
339113 - Surgical Appliance and Supplies Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pleasanton, CA 94588, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $12,000 firm fixed price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit manufacturer of advanced genomic analysis platforms, reagents, and instruments. The contract has an ultimate completion date of July 4, 2026 and is not set aside. 10X Genomics specializes in single-cell and spatial genomic analysis solutions that support...
This is a $19,248 firm fixed price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit manufacturer of advanced genomic analysis platforms, reagents, and instruments. The contract, which has a completion date of January 24, 2026, does not have a set-aside designation. 10X Genomics is providing specialized scientific equipment,...
The Department of Health and Human Services' National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $18,339 firm fixed-price purchase order to 10X Genomics, Inc., doing business as 10X Genomics, located in Pleasanton, California. The contract has a period of performance from June 26, 2023 through June 25, 2024. 10X Genomics will provide their genomic analysis products and services to support the NIH institute's research efforts in...
The National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $10,158 firm fixed price purchase order to 10X Genomics, Inc. for products and services to be delivered between July 2023 and July 2024. 10X Genomics, headquartered in Pleasanton, California, will provide genomic analysis tools and technologies to support NIH research initiatives. No subcontractors or set aside designations were indicated. This purchase augments NIH's ongoing...
This firm fixed price purchase order contract was awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health (NIH), to 10X Genomics, Inc. The $11,000.00 contract provides 10X Genomics' products and services for single-cell and spatial analysis applications to support biomedical research. This includes specialized kits, instruments such as the Chromium Controller and Visium Spatial Gene Expression system, as well as...
This is a firm fixed-price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency within the U.S. Department of Health and Human Services, to 10X Genomics, Inc. The $17,332.00 contract is for the delivery of 10X Genomics' products and services for single-cell and spatial analysis applications, including specialized kits, instruments, and associated installation, training, and support services. The contract has a period of...
This firm fixed price purchase order was awarded by the National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to 10X Genomics, Inc., a life sciences technology company, with a potential value of $12,164.00. The contract has a completion date of May 15, 2025 and was awarded on May 16, 2024. The award is not associated with a set-aside designation. Under this contract, 10X Genomics will provide the NIH with specialized kits, instruments, and...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $185,142.00 firm fixed price purchase order to 10X Genomics, Inc. for reagents compatible with the company's Chromium Controller single cell platform. The contract has a completion date of October 30, 2020 and does not utilize a set-aside designation. 10X Genomics is a life sciences technology company that specializes in products and...
This is a federal contract award to 10X Genomics, Inc., a biotechnology company based in Pleasanton, California. The contract is with the National Institute on Aging, a civilian agency, for the provision of specialized genomic analysis products and reagents, including Chromium Next GEM Single Cell Kits, Visium Spatial Gene Expression systems, and related consumables. The contract is a delivery order with a firm fixed price of $41,767.29 and an ultimate completion date of September 15, 2025....
This federal contract award to 10X Genomics, Inc., a for-profit life sciences technology company, was made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract, valued at $24,270.81, is for the acquisition of a Chromium Next GEN Single Cell 3" Kit V3.1 to support the NIDDK's biomedical research efforts. This fixed-price purchase order does not...